Illumina Ventures Announces Expansion of its Europe Team
sharpening its focus on the European market by bolstering its team and building upon its successes with existing portfolio companies in Europe
Read Moresharpening its focus on the European market by bolstering its team and building upon its successes with existing portfolio companies in Europe
Read Moreto advance its FDA-cleared ANNE® One platform for home and hospital monitoring through global partnerships
Read MoreCompany Advances Clinical Program for its Next Generation Modular Presbyopia-Correcting Intraocular Lens Technology
Read MoreThe new funding will be used to accelerate product development, go-to-market growth, including investment in sales and marketing, and other key hires across the organization.
Read Moreto expand its team as well as extend its commercial reach to broaden patient and physician access to its comprehensive technology-enabled care pathway across the entire continuum of disease presentation
Read MoreTheator extends round amid commercial and company expansion to accelerate rollout of Surgical Intelligence Platform across North America
Read MoreLunit expects to raise approximately KRW 36.4 billion (US$ 28 million) for R&D of its new AI products and global market development
Read MoreRound with Proceeds to be Used to Complete the Company’s Pivotal Study
Read MoreThis funding will support the continued development and commercialization of high-quality and accessible blood tests for single cancer early detection, multi-cancer early detection, and treatment monitoring
Read Moreto expand its commercial team and accelerate the development of its next-generation algorithms for guiding care for high-risk patients
Read More